The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

AccurEdit Therapeutics today announced that its innovative in vivo gene editing product, ART001, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA).

The 2025 Suzhou Shushan Pear Blossom Festival market kicked off in Shushan village, Suzhou High-tech Zone of Jiangsu province ...

China's unwavering commitment to opening-up will propel new industrialization, green growth and digital transformation, ...

A new graphic cookbook — complete with recipes and comic book-style illustrations — tells the backstories of the names behind ...

Here are the latest restaurants, shops and exhibitions to visit in Shanghai during Shanghai Fashion Week's fall 2025 edition.

A 10-time LPGA Tour champion in the United States, Feng found success in Japan as well, securing seven JLPGA titles during ...

A Chinese street food malatang outlet, YangGuoFu Malatang in Suzhou, East China's Jiangsu Province, was ordered to shut down ...

Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...

Covering more than 1,300 square meters, the canteen seats up to 280 diners at a time. It operates with standard breakfast, ...

Explore the evolving economic partnership between China and Argentina, focusing on key sectors like agriculture, energy, and ...

Carlton today announced its highly anticipated debut in the historic city of Suzhou, nestled in China’s Jiangsu province near ...